nature.com search

Loading Filters

Showing 1–20 of 20 results

Loading Filters

Research | 10 August 2006
Cardiovascular drug use and the incidence of erectile dysfunction
- R Shiri
- , J Koskimäki
- , J Häkkinen
- , A Auvinen
- , T L J Tammela
- & M Hakama
International Journal of Impotence Research 19 , 208–212

Rights & permissionsfor article Cardiovascular drug use and the incidence of erectile dysfunction . Opens in a new window.
Research | 2 November 2006
Erectile dysfunction influences the subsequent incidence of lower urinary tract symptoms and bother
- R Shiri
- , J Häkkinen
- , J Koskimäki
- , M Hakama
- , T L J Tammela
- & A Auvinen
International Journal of Impotence Research 19 , 317–320

Rights & permissionsfor article Erectile dysfunction influences the subsequent incidence of lower urinary tract symptoms and bother . Opens in a new window.
21 April 2005
Are questions on both achieving and maintaining an erection needed to define erectile dysfunction?
- J Koskimäki
- , J Häkkinen
- , M Hakama
- , H Huhtala
- , T L J Tammela
- & R Shiri
International Journal of Impotence Research 17 , 335–338

Rights & permissionsfor article Are questions on both achieving and maintaining an erection needed to define erectile dysfunction? . Opens in a new window.
Research | 9 August 2016
Tumor features and survival after radical prostatectomy among antidiabetic drug users
- R M Joentausta
- , P M Kujala
- , T Visakorpi
- , T L J Tammela
- & T J Murtola
Prostate Cancer and Prostatic Diseases 19 , 367–373

Rights & permissionsfor article Tumor features and survival after radical prostatectomy among antidiabetic drug users . Opens in a new window.
11 November 2003 | Open
CHEK2 variants associate with hereditary prostate cancer
- E H Seppälä
- , T Ikonen
- , N Mononen
- , V Autio
- , A Rökman
- , M P Matikainen
- , T L J Tammela
- & J Schleutker
British Journal of Cancer 89 , 1966–1970

Rights & permissionsfor article CHEK2 variants associate with hereditary prostate cancer . Opens in a new window.
15 May 2001 | Open
A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland
- N Mononen
- , T Ikonen
- , K Syrjäkoski
- , M Matikainen
- , J Schleutker
- , T L J Tammela
- , P A Koivisto
- & O P Kallioniemi
British Journal of Cancer 84 , 1344–1347

Rights & permissionsfor article A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland . Opens in a new window.
12 May 2009 | Open
C-reactive protein haplotype is associated with high PSA as a marker of metastatic prostate cancer but not with overall cancer risk
- C M Eklund
- , T L J Tammela
- , J Schleutker
- & M Hurme
British Journal of Cancer 100 , 1846–1851

Rights & permissionsfor article C-reactive protein haplotype is associated with high PSA as a marker of metastatic prostate cancer but not with overall cancer risk . Opens in a new window.
Research | 21 March 2006
Altered levels of Smad2 and Smad4 are associated with human prostate carcinogenesis
- M C Perttu
- , P M Martikainen
- , H S A Huhtala
- , M Bläuer
- , T L J Tammela
- , P J Tuohimaa
- & H Syvälä
Prostate Cancer and Prostatic Diseases 9 , 185–189

Rights & permissionsfor article Altered levels of Smad2 and Smad4 are associated with human prostate carcinogenesis . Opens in a new window.
5 January 2010 | Open
False-positive screening results in the Finnish prostate cancer screening trial
- T P Kilpeläinen
- , T L J Tammela
- , L Määttänen
- , P Kujala
- , U-H Stenman
- , M Ala-Opas
- , T J Murtola
- & A Auvinen
British Journal of Cancer 102 , 469–474

Rights & permissionsfor article False-positive screening results in the Finnish prostate cancer screening trial . Opens in a new window.
Research | 29 May 2012
Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer
- R B Egerdie
- , F Saad
- , M R Smith
- , T L J Tammela
- , J Heracek
- , P Sieber
- , C Ke
- , B Leder
- , R Dansey
- & C Goessl
Prostate Cancer and Prostatic Diseases 15 , 308–312

Rights & permissionsfor article Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer . Opens in a new window.
28 October 2004
Relationship between smoking and erectile dysfunction
- R Shiri
- , M Hakama
- , J Häkkinen
- , T L J Tammela
- , A Auvinen
- & J Koskimäki
International Journal of Impotence Research 17 , 164–169

Rights & permissionsfor article Relationship between smoking and erectile dysfunction . Opens in a new window.
30 September 2003 | Open
Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma
- J P Kallio
- , P Hirvikoski
- , H Helin
- , P Kellokumpu-Lehtinen
- , T Luukkaala
- , T L J Tammela
- & P M Martikainen
British Journal of Cancer 89 , 1266–1269

Rights & permissionsfor article Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma . Opens in a new window.
2 March 2004 | Open
Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer
- K J Savinainen
- , M J Linja
- , O R Saramäki
- , T L J Tammela
- , G T G Chang
- , A O Brinkmann
- & T Visakorpi
British Journal of Cancer 90 , 1041–1046

Rights & permissionsfor article Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer . Opens in a new window.
14 August 2001 | Open
Prognostic utility of human complement factor H related protein test (the BTA stat ^®Test)
- M-P Raitanen
- , E Kaasinen
- , E Rintala
- , E Hansson
- , P Nieminen
- , R Aine
- & T L J Tammela
British Journal of Cancer 85 , 552–556

Rights & permissionsfor article Prognostic utility of human complement factor H related protein test (the BTA stat ®Test) . Opens in a new window.
4 August 2009 | Open
Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial
- T J Murtola
- , T L J Tammela
- , L Määttänen
- , M Ala-opas
- , U H Stenman
- & A Auvinen
British Journal of Cancer 101 , 843–848

Rights & permissionsfor article Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial . Opens in a new window.
4 March 2004
Effect of life-style factors on incidence of erectile dysfunction
- R Shiri
- , J Koskimäki
- , M Hakama
- , J Häkkinen
- , H Huhtala
- , T L J Tammela
- & A Auvinen
International Journal of Impotence Research 16 , 389–394

Rights & permissionsfor article Effect of life-style factors on incidence of erectile dysfunction . Opens in a new window.
9 January 2007 | Open
Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial
- L Määttänen
- , M Hakama
- , T L J Tammela
- , M Ruutu
- , M Ala-Opas
- , H Juusela
- , P Martikainen
- , U-H Stenman
- & A Auvinen
British Journal of Cancer 96 , 56–60

Rights & permissionsfor article Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial . Opens in a new window.
10 July 2014 | Open
Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial
- T Veitonmäki
- , T J Murtola
- , L Määttänen
- , K Taari
- , U-H Stenman
- , T L J Tammela
- & A Auvinen
British Journal of Cancer 111 , 1421–1431

Rights & permissionsfor article Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial . Opens in a new window.
Research | 12 September 2011
Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer
- A Urbanucci
- , B Sahu
- , J Seppälä
- , A Larjo
- , L M Latonen
- , K K Waltering
- , T L J Tammela
- , R L Vessella
- , H Lähdesmäki
- , O A Jänne
- & T Visakorpi
Oncogene 31 , 2153–2163

Rights & permissionsfor article Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer . Opens in a new window.
Research | 23 January 2012
Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer
- S E Jalava
- , A Urbanucci
- , L Latonen
- , K K Waltering
- , B Sahu
- , O A Jänne
- , J Seppälä
- , H Lähdesmäki
- , T L J Tammela
- & T Visakorpi
Oncogene 31 , 4460–4471

Rights & permissionsfor article Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer . Opens in a new window.

Refine your results by…

Filters

Filter By:

Cardiovascular drug use and the incidence of erectile dysfunction

Erectile dysfunction influences the subsequent incidence of lower urinary tract symptoms and bother

Are questions on both achieving and maintaining an erection needed to define erectile dysfunction?

Tumor features and survival after radical prostatectomy among antidiabetic drug users

CHEK2 variants associate with hereditary prostate cancer

A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland

C-reactive protein haplotype is associated with high PSA as a marker of metastatic prostate cancer but not with overall cancer risk

Altered levels of Smad2 and Smad4 are associated with human prostate carcinogenesis

False-positive screening results in the Finnish prostate cancer screening trial

Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer

Relationship between smoking and erectile dysfunction

Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma

Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer

Prognostic utility of human complement factor H related protein test (the BTA stat ^®Test)

Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial

Effect of life-style factors on incidence of erectile dysfunction

Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial

Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial

Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer

Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer

Quick links

Refine your results by…

Filters ​

Filter By:

Search

Quick links

Filters